DISEASE INDICATIONS: Asthma
MANUFACTURER: Amgen / AstraZeneca AB
USAGE: Subcutaneous
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.
